Jiaxing Pan

409 total citations · 1 hit paper
16 papers, 284 citations indexed

About

Jiaxing Pan is a scholar working on Immunology, Biomedical Engineering and Oncology. According to data from OpenAlex, Jiaxing Pan has authored 16 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 6 papers in Biomedical Engineering and 5 papers in Oncology. Recurrent topics in Jiaxing Pan's work include Nanoplatforms for cancer theranostics (6 papers), Phagocytosis and Immune Regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Jiaxing Pan is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Phagocytosis and Immune Regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Jiaxing Pan collaborates with scholars based in China. Jiaxing Pan's co-authors include Haijun Yu, Yi Lai, Zhiai Xu, Leiming Xu, Wen Zhang, Shunan Zhang, Manxiu Huai, Lujia Huang, Fengyang Wang and Shiqin Li and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jiaxing Pan

16 papers receiving 280 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer

2024 58 citations Shunan Zhang, Yi Lai et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiaxing Pan China	9	122	112	70	49	40	16	284
Shiyi Shao China	11	142 1.2×	137 1.2×	68 1.0×	78 1.6×	37 0.9×	18	329
Stephanie J. Wang United States	7	167 1.4×	99 0.9×	101 1.4×	93 1.9×	53 1.3×	9	343
Ning Zeng China	12	126 1.0×	141 1.3×	77 1.1×	53 1.1×	43 1.1×	20	411
Pouria Khani Iran	7	173 1.4×	92 0.8×	72 1.0×	52 1.1×	62 1.6×	13	386
Yutong Lu China	10	140 1.1×	130 1.2×	71 1.0×	87 1.8×	58 1.4×	18	310
Mengying Hou China	11	220 1.8×	141 1.3×	39 0.6×	64 1.3×	87 2.2×	11	411
Shen-Jun Yuan China	9	96 0.8×	156 1.4×	59 0.8×	79 1.6×	88 2.2×	11	328
Zhenzhai Cai China	12	110 0.9×	64 0.6×	84 1.2×	47 1.0×	27 0.7×	26	293
Tongchao Zhao China	9	103 0.8×	45 0.4×	118 1.7×	51 1.0×	25 0.6×	27	317
Zhenmei Yang China	12	126 1.0×	126 1.1×	129 1.8×	141 2.9×	62 1.6×	14	391

Countries citing papers authored by Jiaxing Pan

Since Specialization

Citations

This map shows the geographic impact of Jiaxing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxing Pan more than expected).

Fields of papers citing papers by Jiaxing Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxing Pan. The network helps show where Jiaxing Pan may publish in the future.

Co-authorship network of co-authors of Jiaxing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxing Pan. A scholar is included among the top collaborators of Jiaxing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxing Pan. Jiaxing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Ping, Jiaxing Pan, Bo Peng, et al.. (2025). Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors. Advanced Drug Delivery Reviews. 224. 115620–115620. 2 indexed citations

Huai, Manxiu, Yingjie Wang, Jiaxing Pan, et al.. (2024). Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification. Journal of Nanobiotechnology. 22(1). 257–257. 6 indexed citations

Huai, Manxiu, et al.. (2024). Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. World Journal of Gastroenterology. 30(19). 2575–2602. 32 indexed citations

Li, Mingming, Yi Zhang, Fang Sun, et al.. (2024). Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer. International Journal of Nanomedicine. Volume 19. 9487–9502. 2 indexed citations

Zhang, Shunan, Yi Lai, Jiaxing Pan, et al.. (2024). PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer. Advanced Materials. 36(23). e2314132–e2314132. 58 indexed citations breakdown →

Hou, Bo, Lujia Huang, Fangmin Chen, et al.. (2024). Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy. Science Advances. 10(46). eadq3940–eadq3940. 9 indexed citations

Zhou, Mengxue, Jiaxing Pan, Hui Wang, et al.. (2023). Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy. Nature Communications. 14(1). 3593–3593. 53 indexed citations

Huai, Manxiu, Mingliang Pei, Jiaxing Pan, et al.. (2023). Oral colon-targeted responsive alginate/hyaluronic acid-based hydrogel propels the application of infliximab in colitis. International Journal of Biological Macromolecules. 249. 125952–125952. 18 indexed citations

Pan, Jiaxing, et al.. (2023). Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted. World Journal of Hepatology. 15(6). 725–740. 6 indexed citations

10.

Pan, Jiaxing, Yi Lai, Shunan Zhang, et al.. (2023). Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer. Advanced Materials. 35(47). e2305798–e2305798. 21 indexed citations

11.

Zhang, Huijuan, Jiaxing Pan, Tingting Wang, et al.. (2022). Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer. ACS Applied Materials & Interfaces. 14(35). 39787–39798. 20 indexed citations

12.

Lai, Yi, Yijing Dang, Qian Sun, et al.. (2022). Design of an activatable NIR-II nanoprobe for the in vivo elucidation of Alzheimer's disease-related variations in methylglyoxal concentrations. Chemical Science. 13(42). 12511–12518. 32 indexed citations

13.

Zhang, Shunan, Yi Lai, Jiaxing Pan, et al.. (2022). Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer. Advanced Science. 9(36). e2203263–e2203263. 13 indexed citations

14.

Pan, Jiaxing & Longqian Liu. (2021). Progress of research on infantile nystagmus syndrome. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Pan, Jiaxing, et al.. (2021). Nonocular Influencing Factors for Primary Glaucoma: An Umbrella Review of Meta-Analysis. Ophthalmic Research. 64(6). 938–950. 6 indexed citations

16.

Zhang, Jianbin, Daixi Jiang, Yuqing Cheng, et al.. (2021). Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis. Life Sciences. 270. 119131–119131. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact